DrugPatentWatch Database Preview
Veroscience Company Profile
» See Plans and Pricing
What is the competitive landscape for VEROSCIENCE, and when can generic versions of VEROSCIENCE drugs launch?
VEROSCIENCE has one approved drug.
There are fifteen US patents protecting VEROSCIENCE drugs.
There are twenty-nine patent family members on VEROSCIENCE drugs in thirteen countries.
Summary for Veroscience
| International Patents: | 29 |
| US Patents: | 15 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Veroscience
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Veroscience | CYCLOSET | bromocriptine mesylate | TABLET;ORAL | 020866-001 | May 5, 2009 | RX | Yes | Yes | 8,137,994 | Start Trial | Start Trial | ||||
| Veroscience | CYCLOSET | bromocriptine mesylate | TABLET;ORAL | 020866-001 | May 5, 2009 | RX | Yes | Yes | 10,688,094 | Start Trial | Start Trial | ||||
| Veroscience | CYCLOSET | bromocriptine mesylate | TABLET;ORAL | 020866-001 | May 5, 2009 | RX | Yes | Yes | 7,888,310 | Start Trial | Start Trial | ||||
| Veroscience | CYCLOSET | bromocriptine mesylate | TABLET;ORAL | 020866-001 | May 5, 2009 | RX | Yes | Yes | 8,877,708 | Start Trial | Y | Start Trial | |||
| Veroscience | CYCLOSET | bromocriptine mesylate | TABLET;ORAL | 020866-001 | May 5, 2009 | RX | Yes | Yes | 9,352,025 | Start Trial | Start Trial | ||||
| Veroscience | CYCLOSET | bromocriptine mesylate | TABLET;ORAL | 020866-001 | May 5, 2009 | RX | Yes | Yes | 8,613,947 | Start Trial | Y | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Veroscience
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Veroscience | CYCLOSET | bromocriptine mesylate | TABLET;ORAL | 020866-001 | May 5, 2009 | 5,468,755 | Start Trial |
| Veroscience | CYCLOSET | bromocriptine mesylate | TABLET;ORAL | 020866-001 | May 5, 2009 | 5,756,513 | Start Trial |
| Veroscience | CYCLOSET | bromocriptine mesylate | TABLET;ORAL | 020866-001 | May 5, 2009 | 5,679,685 | Start Trial |
| Veroscience | CYCLOSET | bromocriptine mesylate | TABLET;ORAL | 020866-001 | May 5, 2009 | 5,866,584 | Start Trial |
| Veroscience | CYCLOSET | bromocriptine mesylate | TABLET;ORAL | 020866-001 | May 5, 2009 | 5,716,957 | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Veroscience Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Hong Kong | 1208173 | Start Trial |
| Uruguay | 34776 | Start Trial |
| Japan | 2016026168 | Start Trial |
| European Patent Office | 2437732 | Start Trial |
| Argentina | 091351 | Start Trial |
| Spain | 2755081 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
